SICHUAN, China, February 13, 2012 /PRNewswire-Asia/ -- China Health Resource, Inc. (OTCBB: CHRI.OB News), today announced that they have opened a Princeton, New Jersey office and have appointed Mr. Steven Weiss, a veteran in financial media to head the company's Investor Awareness program. Mr. Steven Weiss will be heading and putting forward an aggressive Investor Awareness Program along with strategic long term financial marketing incentives and acquisitions.
Mr. Weiss brings to us over 30 years of Financial & Media marketing experience with positions at CBS TV, Viacom and Universal Media Group.
Mr. Weiss stated yesterday, "The enormous growth of China Health Resource and their desire to rapidly expand their product base in the USA attracted me here and I am excited to bring my expertise in all avenues of financial marketing to this very undiscovered and undervalued company. Bringing limelight to the investment community is the first order of business. A sound strategy is the bedrock of any Investor Awareness program and nothing contributes more to its ultimate success. Together with Jiayin Wang, Chairman and CEO of China Health Resource along with his staff, we will build a comprehensive powerhouse of a company.
"With the astronomical rise in USA health care costs, many companies no longer offer their employees major health care insurance or are asking for significant co-payments out of their salaries. We strongly feel that given the correct marketing plan that Traditional Chinese Medicine (TCM) will be a very affordable alternative for Americans on strict budgets due to the severe economic environment. I envision a new foundation built upon educating USA citizens on TCM medications that will not only compete with the big pharmaceutical companies but will be a multi-billion dollar revenue foundation for China Health Resource here in the USA," added Mr. Weiss.
Jiayin Wang, the Chairman and CEO of CHRI says: "We are very proud to announce that Mr. Steven Weiss has been appointed to head our strategic financial marketing and investor relations program in the USA. Mr. Weiss credentials are of great caliber - a true renowned veteran in media and investors relations. We are fortunate to have him join us at this time. He will be immediately directing a comprehensive and aggressive Investor Awareness Program for China Health Resource and create wide awareness of our value proposition and mission."
About CHRI
China Health Resource, Inc. engages in the development, manufacturing, processing, marketing and sale of raw and pharmaceutical TCM products including Dahurian Angelica Root (DAR) and Rhizoma Gastrodiae and is the only the provider of GAP quality DAR in the People's Republic of China under the registered Trademark Chuan Baizhi™. DAR, which is also known as "Bai Zhi" in Mandarin Chinese, is an herb that is employed as an ingredient in medicine, cosmetics and food, as well as used in TCM for the treatment of pain, swelling and pustule. The Company's DAR-related products include the Bailing Capsule, Yisheng Capsule, Kimchee-Mate and Fragrant Bag, all of which are sold through regional distributors. The Company was founded in 2001 and is based in Suining, Sichuan Province.
For more information visit www.chinahealthresource.com.
Certain statements in this document regarding financial matters, other than historical facts, and statements of our expectations, intentions, plans and beliefs, constitute "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, that are subject to certain events, risks and uncertainties that may be outside our control. The words "believe", "expect", "anticipate", "optimistic", "intend", "will", and similar expressions identify forward-looking statements. The company intends that such proclamations about future expectations, including future revenues and earnings, future business expansion plans, and all other forward-looking statements be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results. These and other risks and uncertainties related to our business are described in greater detail in our filings with the Commission. The foregoing information should be read in conjunction with these filings. We disclaim any intention or obligation to update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made.
